## **Core Concept**
Non-Hodgkin's lymphoma (NHL) is a type of cancer that originates from lymphocytes, which are a type of white blood cell. The classification of NHL is based on the cell of origin, morphology, genetic features, and clinical presentation. Diffuse large B-cell lymphoma (DLBCL) is a specific subtype of NHL.

## **Why the Correct Answer is Right**
Diffuse large B-cell lymphoma (DLBCL) belongs to the category of **aggressive lymphomas**. It is characterized by the proliferation of large B cells with a high nuclear-to-cytoplasmic ratio, prominent nucleoli, and a diffuse growth pattern. DLBCL is the most common type of NHL and is considered aggressive because it grows rapidly. The correct classification of DLBCL under the given options is related to its aggressive nature and specific pathological features.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might represent a different subtype of lymphoma or a different classification system that does not accurately reflect the aggressive nature and specific characteristics of DLBCL.
- **Option B:** Similarly, this could represent another subtype or classification that does not match the features of DLBCL.
- **Option C:** This option might not accurately represent the specific pathological or clinical features of DLBCL.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for DLBCL is that it often presents with systemic symptoms such as fever, night sweats, and weight loss, and requires prompt treatment, typically with **R-CHOP** (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone), which has significantly improved the prognosis for patients with this disease.

## **Correct Answer:** .